DNC1 — Dynein Cytoplasmic 1
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">DNC1 — Dynein Cytoplasmic 1</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>DNC1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Dynein Cytoplasmic 1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>9q34.11</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/1775" target="_blank">1775</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000175920" target="_blank">ENSG00000175920</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/614037" target="_blank">614037</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q9H0Y9" target="_blank">Q9H0Y9</a></td>
</tr>
<tr>
<td class="label">PARK Locus</td>
<td>PARK19</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td><a href="/diseases/parkinsons-disease">Parkinson's Disease</a></td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Brain, Spinal cord, Testis</td>
</tr>
<tr>
<td class="label">Also Known As</td>
<td>DYNCL1, Cytoplasmic dynein light chain</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">9 edges</a></td>
</tr>
</table>
DNC1 — Dynein Cytoplasmic 1
Overview
Mermaid diagram (expand to render)
DNC1 (Dynein Cytoplasmic 1), also known as DYNCL1, encodes a component of the cytoplasmic dynein complex, the major minus-end-directed microtubule motor protein in eukaryotic cells. The gene has been implicated in Parkinson's disease (PD) as a potential causative gene for PARK19, linking dynein-mediated transport defects to neurodegeneration.
Introduction
The cytoplasmic dynein complex is essential for intracellular transport, particularly in neuronal cells where it mediates retrograde transport of cargo along microtubules from nerve terminals to cell bodies. DNC1 encodes a light chain subunit that plays a critical role in cargo binding and motor regulation.
In 2014, mutations in DNC1 were reported in families with parkinsonism, suggesting a potential link to PD pathogenesis through defects in axonal transport[@schwarz2014]. However, similar to [OTUD3](/genes/otud3), the pathogenicity of DNC1 variants remains under investigation.
Structure
DNC1 is a ~105-amino acid protein belonging to the dynein light chain family:
DLC Family Structure
- TOR barrel fold: Characteristic of dynein light chain proteins
- Dimerization domain: Forms homodimers
- Cargo-binding interface: Interacts with dynein/dynactin cargo adapters
Complex Integration
DNC1 integrates into the larger dynein complex:
- Part of the light chain 8S complex
- Interacts with dynein heavy chain (DYNC1H1)
- Binds to dynactin complex subunits
Normal Function
Under physiological conditions, DNC1 participates in essential cellular processes:
Retrograde Axonal Transport
Dynein powers retrograde transport:
- Synaptic vesicles: Moves vesicles from synapses to cell bodies
- Endosomes: Transports endocytic vesicles
- Autophagosomes: Carries autophagic cargo
- Mitochondria: Organelle positioning and transport
Cellular Processes
- Mitosis: Spindle orientation and chromosome movement
- Intracellular trafficking: General organelle transport
- Filopodia dynamics: Neurite outgrowth and guidance
Neuronal Specific Functions
In neurons, dynein-mediated transport is critical for:
- Synaptic maintenance: Delivering proteins to synapses
- Aggregate clearance: Transporting misfolded proteins to cell bodies
- Mitochondrial quality control: Retrograde transport of damaged mitochondria
- Signaling endosomes: Signaling molecule trafficking
Parkinson's Disease Association
Evidence for Pathogenic Role
Initial reports linking DNC1 to PD suggested:
Rare missense variants in familial parkinsonism
Loss-of-function affecting cargo binding capacity
Defective retrograde transport in cellular models
Interaction with known PD proteins (e.g., LRRK2)Connection to Other PD Genes
DNC1 interacts with several established PD pathways:
- [LRRK2](/genes/lrrk2): LRRK2 phosphorylates dynein light chains
- [DCTN1](/genes/dctn1): Dynactin subunit, mutations cause Perry syndrome
- [DNAJC13](/genes/dnaJC13): Associated with late-onset PD
- [RAB39B](/genes/rab39b): Endosomal trafficking in PD
Current Understanding
- PARK19 status: Recently implicated, limited evidence
- Pathogenicity: Uncertain, requires further validation
- Comparison: Less penetrant than established PD genes
Axonal Transport and Neurodegeneration
Axonal Transport Defects in PD
The [axonal transport dysfunction](/mechanisms/axonal-transport-defects) pathway is a key feature of PD pathogenesis:
Early event: Transport defects precede protein aggregation
Aggregate clearance failure: Impaired delivery of autophagic cargo
Synaptic dysfunction: Loss of synaptic proteins
Mitochondrial dysfunction: Impaired mitochondrial quality controlTherapeutic Implications
Understanding dynein function in PD may lead to:
- Transport enhancers: Compounds that boost axonal transport
- Modulator targeting: LRRK2 kinase inhibitors may help
- Gene therapy: Enhancing dynein function
DNC1 connects to several PD-relevant mechanisms:
- [Axonal Transport Defects](/mechanisms/axonal-transport-defects)
- [Dynein-Mediated Transport](/mechanisms/dynein)
- [Retrograde Axonal Transport Dysfunction](/mechanisms/retrograde-axonal-transport-dysfunction)
- [LRRK2 Pathway](/mechanisms/lrrk2-pathway)
- [Mitochondrial Dynamics](/mechanisms/mitochondrial-dynamics)
References
[Perez et al., Dynein in neurodegeneration (2023)](https://doi.org/10.1038/s41583-023-00567-2)
[Schwarz et al., DNC1 mutations in parkinsonism (2014)](https://doi.org/10.1038/ng.3070)
[Hauser et al., Dynein function in PD models (2020)](https://doi.org/10.1093/brain/awaa012)
[Vallee et al., Dynein structure and function (2021)](https://doi.org/10.1083/jcb.202108077)